DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Mayer EL, Abramson VG, Jankowitz RC. et al.
TBCRC030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC–Evaluating the homologous recombination deficiency (HRD) biomarker.
J Clin Oncol 2019;
37 (Suppl.) Abstr.. 507
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.